Good week for healthcare after Big Pharma reports positive second quarter and mid-year results, ...

Read More

The recent peso depreciation has caused a price increase in medicine in Mexico, particularly ...

Read More

Interview with Cristóbal Thompson, Executive Director of AMIIF Q: What are AMIIF’s main priorities ...

Read More

Raul Camarena, General Manager of Aspen Labs, spoke to Mexico Health Review on the ...

Read More

Biotech firm Amgen has developed a new drug that could help address cardiovascular diseases, ...

Read More